In oncology we are always asking questions about which treatment option is best. And that focus on the next best treatment may prevent us from rethinking some fundamentals of current practice. Three recent studies illustrate this and made me ask:
Do we need a Port or PICC for every testicular cancer patient?
Study: https://doi.org/10.1200/OP.23.00580
Editorial: https://doi.org/10.1200/OP.23.00730
Is vaginal estrogen safe if breast cancer patients?
Study: https://jamanetwork.com/journals/jamaoncology/article-abstract/2811413
Does paclitaxel work differently than we always thought?
Study: https://doi.org/10.1371/journal.pbio.3002339
